CG
TARO

Cutler Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Cutler Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,500
Closed -$6K – 7498
2016
Q3 		$6K Sell
1,500
-300
-17% -$39.7K ﹤0.01% 4835
2016
Q2 		$2K Buy
+1,800
New +$255K ﹤0.01% 5811
2016
Q1 		– Sell
-4,500
Closed -$33K – 7380
2015
Q4 		$33K Buy
+4,500
New +$657K ﹤0.01% 2897

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cutler Group's TARO Position: Q2 2022 in Review

Cutler Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2022, closing a stake of 420 shares — an estimated $16K sold.

Cutler Group first reported a position in TARO in Q1 2016 and held it in 18 quarters. The position peaked at $143K in Q1 2016. 72 funds tracked by Wall St. Rank hold TARO as of Q2 2022.

  • Cutler Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 420 Taro Pharmaceutical Industries Ltd. shares in Q2 2022, an estimated $16K.
  • Cutler Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 18 quarters.
  • Cutler Group's Taro Pharmaceutical Industries Ltd. position peaked at $143K in Q1 2016.
  • 72 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.